Bumper Offer - Urjas oil Just @ Rs. 1 X
Saferet 5 Mg Tablet (30) is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Pimples.
Medical history of the patient along with age and gender determines the dosage of Saferet 5 Mg Tablet (30). Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Saferet 5 Mg Tablet (30) side effects, there are can be others also. These have been listed below. Normally, these side effects of Saferet 5 Mg Tablet (30) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Saferet 5 Mg Tablet (30)'s effect during pregnancy is Severe and Moderate while nursing. Warnings related to Saferet 5 Mg Tablet (30)'s effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Depression must refrain from the use of Saferet 5 Mg Tablet (30) since this can cause severe adverse effects. Some other conditions that can be affected by Saferet 5 Mg Tablet (30) are listed in the contraindications section below.
Drug interactions for Saferet 5 Mg Tablet (30) have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Saferet 5 Mg Tablet (30) is considered safe while driving, and is addictive.
Saferet 5 Mg Tablet (30) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Saferet 5 Mg Tablet (30) is used -
Moderate
Mild
Is the use of Saferet 5 Mg Tablet (30) safe for pregnant women?
Saferet shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Saferet 5 Mg Tablet (30) safe during breastfeeding?
Saferet may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Saferet, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Saferet.
What is the effect of Saferet 5 Mg Tablet (30) on the Kidneys?
Saferet may have mild side effects on the kidneys.
What is the effect of Saferet 5 Mg Tablet (30) on the Liver?
Saferet can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Saferet 5 Mg Tablet (30) on the Heart?
Saferet may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Saferet 5 Mg Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Saferet 5 Mg Tablet (30) unless your doctor advises you to do so -
Is this Saferet 5 Mg Tablet (30) habit forming or addictive?
No, you will not get addicted to Saferet 5 Mg Tablet (30).
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Saferet 5 Mg Tablet (30) since it will not make you feel sleepy.
Is it safe?
Yes, but consume Saferet 5 Mg Tablet (30) only on doctor's advice.
Is it able to treat mental disorders?
No, Saferet 5 Mg Tablet (30) cannot treat any kind of mental disorder.
Interaction between Food and Saferet 5 Mg Tablet (30)
Saferet 5 Mg Tablet (30) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Saferet 5 Mg Tablet (30)
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)